Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the safety and immune response of a combined Hepatitis A/B vaccine with the MenACWY-CRM meningococcal conjugate vaccine has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A
• Hepatitis B
• Meningococcal Disease
• Meningococcal Meningitis

Drugs mentioned

• Combined Hepatitis A/B vaccine (combined hepatitis A and B vaccine)
• MenACWY-CRM Conjugate Vaccine (Meningococcal ACWY CRM197 conjugate vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningococcal Disease, Meningococcal Meningitis | Phase 3 | Status: COMPLETED | Results posted: 2014-03-10